Skip to main content
. 2024 Feb 16;147(5):543–554. doi: 10.1159/000536548

Fig. 1.

Fig. 1.

Timeline of study including survey period relative to state-wide strict lockdowns for COVID-19. People with haematological malignancies were eligible for COVID-19 vaccination from the commencement of the Australian Government Rollout Phase 1B. MH, Monash Health; VIC, Victoria; BH, Bendigo Health; LRH, Latrobe Regional Hospital; SCHHS; Sunshine Coast Hospital and Health Service; QLD; Queensland; CCH, Central Coast Haematology; NSW, New South Wales; ICCH, Icon Cancer Centre Hobart; TAS, Tasmania; BMO, Border Medical Oncology; SVHS, St Vincent’s Hospital Sydney; CH, Campbelltown Hospital; ATAGI, Australian Technical Advisory Group on Immunisation; TGA, Therapeutic Goods Administration – COVID-19 Vaccine Provisional Registration; AZ, AstraZeneca; yrs, years.